Practical Law IP&IT subscribers now have access to the fully revised and updated Life Sciences multi-jurisdictional guide to life sciences law and lawyers worldwide.

In Germany, a new transparency code has been recently introduced, to follow the requirements of the European Federation of Pharmaceutical Industries and Associations. According to the new code, for the first time member companies must disclose payments and other benefits to healthcare professionals and organisations from 2016 onwards. For further information on the restrictions on marketing practices for healthcare establishments and medical practitioners in Germany, see Medicinal product regulation and product liability in Germany: overview, by Clifford Chance LLP.

The guide also features Q&A guides to Medicinal product regulation and product liability that give an overview of issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, patents, trade marks, and product liability. The Pharmaceutical IP and competition law Q&A chapters give an overview of pharmaceutical patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports. In addition, answers to questions can be compared across jurisdictions to assist cross-border transactions (see the Medicinal product regulation and product liability: Country Q&A tool and the Pharmaceutical IP and Competition Law: Country Q&A tool).